Very Low Evidence
Research Overview
Dihexa Research for Cognitive Enhancement
An evidence-based overview of research examining Dihexa in the context of cognitive enhancement. This page synthesizes findings from peer-reviewed literature.
Research Summary
Dihexa was developed as a cognitive enhancer based on HGF/c-Met pathway modulation. Rodent studies showed reversal of scopolamine-induced memory deficits at extremely low doses. No human trials have been conducted, and all preclinical data comes from a single research group.
Referenced Studies
Click any PMID to view the full study on PubMed.
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. Always consult a healthcare provider before making health decisions.